Outset Medical (OM) Net Income towards Common Stockholders (2019 - 2026)
Outset Medical (OM) posted quarterly Net Income towards Common Stockholders of -$19.0 million for Q1 2026, up 26.39% year-over-year from -$15.0 million in Q1 2025, and up 2.63% quarter-over-quarter from -$19.5 million in Q4 2025.
Outset Medical (OM) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Outset Medical (OM) has reported Net Income towards Common Stockholders for 8 consecutive years, with -$19.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 26.39% year-over-year to -$19.0 million; the TTM figure through Mar 2026 stood at -$74.8 million (up 34.24% YoY), while the FY2025 annual figure was -$81.7 million, up 36.2% from the prior year.
- Net Income towards Common Stockholders advanced to -$19.0 million in Q1 2026 per OM's latest filing, from -$19.5 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$17.8 million in Q3 2025 and bottomed at -$46.2 million in Q3 2023.
- Historically, Net Income towards Common Stockholders has averaged -$33.2 million across 5 years, with a median of -$36.9 million in 2022.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 45.12% — and 2025, when it jumped 46.19%.
- Outset Medical's Net Income towards Common Stockholders stood at -$41.4 million in 2022, then increased by 6.86% to -$38.6 million in 2023, then surged by 33.58% to -$25.6 million in 2024, then advanced by 23.98% to -$19.5 million in 2025, then increased by 2.63% to -$19.0 million in 2026.
- Business Quant data shows OM's Net Income towards Common Stockholders at -$19.0 million in Q1 2026, -$19.5 million in Q4 2025, and -$17.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Outset Medical | 80.25 Mn | -182.94 Mn | 13.28 Mn | -17.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.98 Mn |
| Mar 31, 2026 | -18.98 Mn |
| Dec 31, 2025 | -19.49 Mn |
| Sep 30, 2025 | -17.84 Mn |
| Jun 30, 2025 | -18.54 Mn |
| Mar 31, 2025 | -25.78 Mn |
| Dec 31, 2024 | -25.64 Mn |
| Sep 30, 2024 | -27.94 Mn |
| Jun 30, 2024 | -34.45 Mn |
| Mar 31, 2024 | -39.94 Mn |
| Dec 31, 2023 | -38.60 Mn |
| Sep 30, 2023 | -46.18 Mn |
| Jun 30, 2023 | -44.05 Mn |
| Mar 31, 2023 | -43.97 Mn |
| Dec 31, 2022 | -41.44 Mn |
| Sep 30, 2022 | -40.78 Mn |
| Jun 30, 2022 | -43.84 Mn |
| Mar 31, 2022 | -36.89 Mn |
| Dec 31, 2021 | -41.23 Mn |
| Sep 30, 2021 | -30.47 Mn |